Mirae Asset Global ETFs Holdings
COLL icon

Mirae Asset Global ETFs Holdings’s Collegium Pharmaceutical COLL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
15,166
+447
+3% +$15.3K ﹤0.01% 1952
2026
Q1 		$487K Buy
14,719
+97
+0.7% +$4.11K ﹤0.01% 1900
2025
Q4 		$677K Sell
14,622
-267
-2% -$11.2K ﹤0.01% 1733
2025
Q3 		$521K Sell
14,889
-2,671
-15% -$92.8K ﹤0.01% 1853
2025
Q2 		$519K Sell
17,560
-1,486
-8% -$42.4K ﹤0.01% 1801
2025
Q1 		$569K Buy
19,046
+825
+5% +$25.2K ﹤0.01% 1805
2024
Q4 		$522K Buy
18,221
+339
+2% +$11.2K ﹤0.01% 1895
2024
Q3 		$691K Buy
17,882
+1,612
+10% +$57.5K ﹤0.01% 1748
2024
Q2 		$524K Buy
+16,270
New +$564K ﹤0.01% 1804

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's COLL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Collegium Pharmaceutical (COLL) stake by 3% in Q2 2026, buying an estimated $15.3K and bringing the position to 15,166 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Mirae Asset Global ETFs Holdings first reported a position in COLL in Q2 2024 and has held it in 9 quarters since. The position peaked at $691K in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 15,166 shares of Collegium Pharmaceutical worth $549K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 447 Collegium Pharmaceutical shares in Q2 2026, an estimated $15.3K.
  • Collegium Pharmaceutical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1952 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Collegium Pharmaceutical position peaked at $691K in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.